AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2016
Jun 6, 2016
31949_dirs_2016-06-06_d5f9d3d5-b462-4665-ae0a-d0443073ffee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-04-18
Reporting Person: Palti Yoram (Director, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-18 | Ordinary Shares | M | 147825 | $0.17 | Acquired | 147825 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-18 | Options to Buy Ordinary Shares | $0.17 | M | 147825 | Disposed | 2016-12-25 | Ordinary Shares (147825) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 1671054 | Indirect |
Footnotes
F1: Professor Palti shares voting and investment power for the shares held by Bennett Limited.
F2: Fully vested and exercisable.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3